Start with the reason you are reconsidering implants
Your first question may concern discomfort, a change in appearance, a device finding or simply wanting a different body shape. Write down what brought you to this point and what you hope would change. These priorities help the surgeon explain which parts of a proposed operation address a medical concern and which address appearance.
The FDA emphasizes that breast implants are not lifetime devices and that further surgery may become necessary. Replacement begins another period of living with an implant and its possible complications. An implant's age belongs in the assessment, but this guide does not set an automatic replacement deadline. [1]
Bring available implant cards, earlier operation reports and breast imaging. Make a simple history of placement, exchanges and the start of any symptoms, marking uncertain dates as uncertain. Ask the practice to help obtain missing records rather than guessing the manufacturer, filling or surface type.
Clarify the finding before choosing the operation
A saline implant rupture can cause deflation and a noticeable size change. Silicone rupture may be silent, so appearance and a physical examination alone cannot reliably exclude it. MRI is the most effective method for identifying silent silicone rupture; ultrasound is an accepted screening alternative for people without symptoms. Suspected rupture needs clinical assessment and an individualized management discussion. [3]
The consultation includes medical conditions, allergies, previous treatment, medicines, supplements and tobacco or other substance use. Give a complete account even when something seems unrelated to your breasts. This helps the team assess surgical risks and the information needed before recommending an approach. [2]
Ask the surgeon to distinguish a confirmed finding from a possibility still being investigated. Which imaging or other result would change the plan? If two clinicians have offered different explanations, bring both reports and ask how the disagreement will be resolved before you commit.
Compare removal and replacement as different goals
Implant revision can replace existing implants and may also address their size, position or the surrounding breast shape. Some plans include a lift or reduction. Ask which components are proposed for you and why; changing the implant and changing the breast tissue are related but distinct parts of the plan. [4]
After removal without replacement, the result depends on the previous implant and the amount and quality of remaining tissue. Existing scar tissue also matters. Early swelling can obscure the outcome, and another procedure may sometimes be needed. Removal does not guarantee a return to your pre-implant appearance. [5]
Request a comparison in everyday terms: likely volume, looseness, scars and what remains uncertain. Ask whether reshaping would be considered now or reassessed later, and whether you can choose removal alone. If your implants followed mastectomy, ask your reconstructive team to explain options that fit your cancer-treatment history and priorities.
Separate the choices in your consultation
| Choice | What it concerns | Question to ask |
|---|---|---|
| Removal alone | The existing implant, with a separate capsule decision. [3] | What shape and loose tissue should I expect? |
| Removal and replacement | A new implant, sometimes with additional reshaping. [4] | Why this device and this size? |
| Capsulectomy | Some or all of the surrounding capsule. [6] | What finding supports that extent? |
| Investigation first | Symptoms or findings that need clarification. | What result would change the operation? |
| Monitoring after assessment | A defined follow-up plan when surgery is deferred. | Which changes should prompt an earlier review? |
These decisions can overlap. The table is a discussion guide, not a treatment recommendation.
Use precise language about the capsule
The capsule is scar tissue surrounding an implant. Implant removal can sometimes leave it in place. The FDA notes that this requires less dissection and may reduce local complications such as bleeding. Whether any capsule should remain is a separate clinical decision from whether to replace the implant. [3]
The Breast Surgery Collaborative Community defines partial capsulectomy as removing some capsule; total capsulectomy removes all of it, potentially in pieces. Total intact capsulectomy removes the whole capsule as one unit. En bloc capsulectomy additionally includes a margin of uninvolved tissue and is indicated for suspected or established implant-associated cancer after appropriate investigation. These terms are not interchangeable. [6]
Possible reasons to consider capsulectomy include contracture, rupture or a capsule abnormality. Benefits must be weighed against surgical risks. It remains unknown whether capsulectomy prevents future implant-associated cancer. Ask what specific finding supports the proposed extent of removal and how the surgeon will respond if safely removing every part proves difficult. [6]
Discuss systemic symptoms without promising a cure
People use breast implant illness, or BII, for systemic symptoms reported after implantation, including fatigue, difficulty concentrating and joint symptoms. The FDA says the causes and relationship to implants remain unclear. There is no specific diagnostic test or accepted set of criteria for BII. Some patients report improvement after removal, but an individual outcome cannot be guaranteed. [7]
Bring a symptom timeline and any previous investigations. Ask who will assess other possible explanations and who will follow you after surgery if symptoms continue. Describing the effect on work, sleep and ordinary activities can make your concerns easier to discuss than trying to settle every disputed mechanism during one appointment.
Before deciding, ask what improvement the surgeon considers plausible, what evidence supports that view and how uncertainty affects the recommendation. Keep the symptom discussion separate from promises about breast shape. You should be able to understand both reasons for surgery and what care remains available if the hoped-for change does not happen.
Understand cancer concerns and the role of investigation
BIA-ALCL is a lymphoma of the immune system that can develop around an implant; it is different from breast cancer. Risk is higher with textured implants than smooth implants. Persistent swelling, a mass or pain around an implant needs evaluation, which may include imaging and testing surrounding fluid or tissue. A diagnosis can change the operation, so investigation should inform surgical planning. [8]
The FDA has also received reports of squamous cell carcinoma, or SCC, in implant capsules. These occurrences may be rare, but their cause, frequency and risk factors remain unknown. For people without symptoms, the FDA does not recommend removal solely because of concern about SCC or other reported lymphomas. [9]
Ask the surgeon to explain how the evidence applies to your current and previous devices. Request clear language about what is known, what remains uncertain and what would trigger further investigation. A personal decision about preventive surgery should include the risks of the operation as well as your concerns about retaining the implants.
Make the preparation plan specific
Preparation may include testing, a medical assessment and a review of medicines. Follow the instructions agreed with your surgical and prescribing teams rather than changing medicines yourself. For outpatient removal, ASPS advises arranging transport and having someone stay with you for at least the first night. [10]
Confirm the exact operation on each side, the facility, anesthesia arrangements and who provides follow-up. Ask how unexpected findings might alter the planned procedure and how those possibilities will be covered in consent. Request written instructions early enough to ask questions before the surgery date.
Give your helper practical information: when to arrive, where instructions will be kept and whom to call. Arrange responsibility for shopping, dependents and appointments. If you travel for care, ask who would examine you locally if a concern arises after you return home.
Include complications and the complete cost
Implant removal carries risks including bleeding, infection, fluid collections, altered nipple or areola sensation, poor incision healing and anesthesia complications. Ask which are most relevant to your health and proposed operation. The extent of capsule surgery and any additional procedures belong in that discussion. [11]
A quoted surgeon's fee may exclude anesthesia, operating-room charges and other expenses. Coverage varies, so confirm the insurer's decision and the practice's written estimate for your actual plan. Do not assume that a replacement device, additional reshaping or future care is included in a removal quote. [12]
Ask what happens if recovery requires extra visits, dressings or another procedure. Add transport, childcare and time away from work to your own budget. Compare the scope and follow-up attached to each quote; the name of an operation alone does not tell you everything it includes.
Plan recovery around tasks and support
Dressings, a support garment and temporary drains may be used after removal. Your instructions should explain wound care, medicines, concerning changes and follow-up. Ask the team when you can shower, resume activity and exercise, and how drain decisions will be made. Recovery advice needs to match your individual operation. [13]
Describe your actual work and home duties. A desk job, carrying equipment and lifting a child place different demands on a recovery plan. Ask for written restrictions that you can share with your employer or helper, plus a review point for deciding when those restrictions can change.
Keep appointments and contact details in one place. If you have drains, ask for a demonstration of any care or recording tasks before discharge. Confirm how to reach the practice after hours and what to do if you cannot reach them. Avoid treating someone else's recovery diary as a deadline you must meet.
Build a decision you can explain
- 01Gather
Bring device records, imaging, a symptom timeline and personal priorities.
- 02Assess
Clarify findings and any investigation needed before choosing surgery.
- 03Compare
Discuss the implant, capsule and reshaping decisions separately.
- 04Prepare
Confirm support, costs, urgent contacts and continuing follow-up.
An individualized sequence, with no fixed recovery timetable.
Leave with a plan beyond the operation
For silicone implants without symptoms, FDA labeling guidance recommends ultrasound or MRI beginning five to six years after implantation, then every two to three years. Symptoms or an uncertain ultrasound can call for MRI sooner. This rupture surveillance does not replace breast-cancer screening appropriate to your history. Confirm the schedule for any retained or replacement implants with your clinician. [14]
Ask for copies of the operative summary, relevant pathology and any new implant card. Have the team state who will explain results, when that discussion will occur and who takes responsibility for longer-term follow-up. If implants are removed, ask what breast assessment remains appropriate for you.
Revisit the priorities that started the conversation. Can you explain why you prefer this option, the role of capsule removal and the trade-offs you accept? A considered decision may be surgery, further investigation or continued monitoring after assessment. The goal is a clear, individualized plan you understand.
Your consultation checklist
Use these checkboxes to track questions. Your selections are not saved when you leave the page.
When to contact your team or seek urgent care
- Seek emergency medical attention for shortness of breath, chest pain or unusual heartbeats after surgery. [5]
- Arrange prompt evaluation for persistent breast swelling, a new mass or pain around an implant, including changes years after placement. [8]
- Contact the surgical team promptly for the wound or general-health warning signs specified in your discharge instructions or unexpected deterioration. [13]
Frequently asked questions
Does removal always require capsulectomy?
No. The FDA describes implant removal with the capsule left in place as one option. The reason for surgery and individual findings guide whether some or all should be removed. [3]
Is total intact removal the same as en bloc?
No. En bloc includes a margin of uninvolved tissue for suspected or established implant-associated cancer. Removing an intact capsule alone is a different procedure. [6]
Will removal resolve fatigue or brain fog?
It cannot be promised. Some patients report improvement, while the causes and relationship of systemic symptoms to implants remain uncertain. Discuss ongoing assessment and follow-up as well as surgery. [7]
Should symptom-free people remove implants because of BIA-ALCL?
The FDA does not recommend removal solely over BIA-ALCL concern when there are no symptoms. Discuss your device history, concerns and individual choices with your surgeon. [8]
Can I know my final shape immediately?
No. Swelling and postoperative changes need time to settle. Remaining tissue and the previous implant influence the result, and a single operation may not achieve every goal. [5]
When can I return to exercise?
Ask for instructions tied to your procedure and follow-up findings. The team should specify permitted activity and the next review; a universal return date would be misleading. [13]
Continue reading
Sources & editorial notes
Source review: September 28, 2026. Numbered citations link to the sources below.
- [1]U.S. Food and Drug Administration
What to Know About Breast Implants - [2]American Society of Plastic Surgeons
Breast Implant Removal Consultation - [3]U.S. Food and Drug Administration
Risks and Complications of Breast Implants - [4]American Society of Plastic Surgeons
Breast Implant Revision - [5]American Society of Plastic Surgeons
Breast Implant Removal Results - [6]Breast Surgery Collaborative Community
Consensus Statement on Capsulectomy Terminology and Management - [7]U.S. Food and Drug Administration
Medical Device Reports for Systemic Symptoms in Women with Breast Implants - [8]U.S. Food and Drug Administration
Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) - [9]U.S. Food and Drug Administration
UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants — Safety Communication - [10]American Society of Plastic Surgeons
Breast Implant Removal Preparation - [11]American Society of Plastic Surgeons
Breast Implant Removal Risks and Safety - [12]American Society of Plastic Surgeons
Breast Implant Removal Cost - [13]American Society of Plastic Surgeons
Breast Implant Removal Recovery - [14]U.S. Food and Drug Administration
Breast Implants — Certain Labeling Recommendations to Improve Patient Communication
Purpose and review status. Prepared by Celebrity Plastic Surgeons Magazine for general patient education. This article is not a diagnosis or personal treatment plan and does not claim independent clinical peer review. A qualified clinician should assess symptoms, suitability and recovery.
Photography. Photographs credited to Antoni Shkraba — Pexels License. Resized and cropped for layout.; SHVETS production — Pexels License. Resized and cropped for layout.. Stock models are not presented as surgical patients or endorsers.
Visual comparisons. Tables and planning guides summarize the cited sources and questions to discuss. They are not measured outcome charts, individual risk estimates or recovery clearance.
Editorial responsibility. Published by MedNova Publications. The star mark is the existing CPS website icon. Referenced organizations are information sources; their mention does not imply endorsement. Send source-supported corrections to contact@celebrityplasticsurgeons.com.